Towards stem cell based therapies for Parkinson's disease (Q47877645)

6 February 2018

title

Towards stem cell based therapies for Parkinson's disease (English)

1 reference

6 February 2018

1 reference

6 February 2018

language of work or name

English

0 references

publication date

8 January 2018

1 reference

6 February 2018

published in

Development

1 reference

6 February 2018

volume

145

1 reference

6 February 2018

issue

1 reference

6 February 2018

page(s)

dev156117

1 reference

Cell-based therapies for Parkinson disease—past insights and future potential

13 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Identification of midbrain floor plate radial glia-like cells as dopaminergic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Direct generation of functional dopaminergic neurons from mouse and human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Efficient derivation of functional floor plate tissue from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Single-Cell Analysis Reveals a Close Relationship between Differentiating Dopamine and Subthalamic Nucleus Neuronal Lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

GRNOPC1: the world's first embryonic stem cell-derived therapy. Interview with Jane Lebkowski

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Genetic and epigenetic variations in iPSCs: potential causes and implications for application

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

MHC matching improves engraftment of iPSC-derived neurons in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Direct conversion of human fibroblasts to dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Induced pluripotent stem cell technology: a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Strategies for bringing stem cell-derived dopamine neurons to the clinic: The Kyoto trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Progress of stem/progenitor cell-based therapy for retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

Direct conversion of fibroblasts to functional neurons by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1242%2FDEV.156117

21 January 2018

Identifiers

DOI

10.1242/DEV.156117

1 reference

6 February 2018

1 reference

6 February 2018